News | News By Subject | News by Disease News By Date | Search News

Glaucoma News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Amid Insider Trader Investigations, Acucela (AUCL) and Otsuka Pharma Kill Glaucoma Drug Deal After Failed Trial     6/14/2016
Gilead (GILD) May Take Page Out of Pfizer (PFE)'s Game Plan as Firm Hunts for M&As to Sustain Growth     2/4/2016
Aerie (AERI) Shares Soar After Glaucoma Drug Meets Late Stage Endpoints     9/17/2015
Aerie (AERI) Freefalls Aftermarket as Rhopressa Fails Phase III Study     4/27/2015
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
NicOx SA (COX.PA) Gets Boost From Strong Prospects For Glaucoma Drug Vesneo     9/25/2014
Aerie Pharmaceuticals, Inc. (AERI) Soars As Combo Eye Drug Roclatan Performs Well In Phase 2b Trial; Stock Up +28.29% At Market Close (June 25, 2014)     6/26/2014
Amakem NV to Present Top-Line Clinical Results for its Lead Candidate, AMA0076, at Ophthalmology Innovation Summit at the American Academy of Ophthalmology Meeting 2013     11/7/2013
Inotek Pharmaceuticals Corporation Collects $21 Million for Development of Glaucoma Drug     9/27/2013
FDA Approves Novartis AG (NVS)'s Simbrinza for Glaucoma     4/22/2013
Sucampo Pharmaceuticals, Inc. (SCMP) Gets Nod for Glaucoma Drug From FDA     12/12/2012
Aerie Pharmaceuticals, Inc. Gets Good News on Glaucoma Treatment     11/2/2012
FDA Approves Merck & Co., Inc. (MRK) Drug for Glaucoma     2/15/2012

News from Around the Web
Smoking Pot May Give You Better Night Vision     11/1/2016
Why Apnea Patients Are Prone To Suffer From Glaucoma, Hokkaido University Study     7/25/2016
New Eye Test Could Detect Glaucoma Years Earlier, University of New South Wales Study     7/13/2016
Current Stimulation Of The Brain Restores Vision In Patients With Glaucoma And Optic Nerve Damage, Otto-von-Guericke University Of Magdeburg Study     6/30/2016
Green, Leafy Vegetable May Lower Glaucoma Risk, Brigham and Women's Hospital Study     1/15/2016
Three New Glaucoma-Related Genes Discovered, National Eye Institute Researchers Reveal     1/12/2016
Tiny Medical Device Helps Treat Glaucoma     8/13/2015
Newcomers Like Aerie Pharmaceuticals, Inc. (AERI), Inotek Pharmaceuticals Corporation Aim to Shake Up Big Pharma With New Wave of Glaucoma Drugs     2/10/2015
Most Commonly Prescribed Glaucoma Drug Reduces Risk Of Vision Loss By More Than 50% Over 2 Years: Lancet     12/19/2014
Migraine Pain Stopped With Glaucoma Medicine, Doctors Say     9/12/2014
Glaucoma May Be A Brain Disease, Association for Research in Vision & Ophthalmology Reveals     6/10/2014
New Eye Layer Has Possible Link To Glaucoma, University of Nottingham Study     2/18/2014
Glaucoma Drug Can Cause Droopy Eyelids, Massachusetts Eye and Ear Study     5/22/2013
Rapid Eye Movements Significantly Delayed in People With Glaucoma, St. Michael's Hospital Study     12/7/2012
Glaucoma Drug May Reverse Baldness, University of Bradford Study     10/30/2012

Press Releases
USC Roski Eye Institute Conducted Patient Trials For Breakthrough Refractory Glaucoma Treatment     11/23/2016
Allergan (AGN) Wins FDA Nod for the XEN Gel Stent, a New Surgical Treatment for Refractory Glaucoma     11/22/2016
Envisia Therapeutics Releases ENV515 (Travoprost XR) Phase 2 Data Showing Nine-Month Duration Of Action After A Single Dose In Patients With Glaucoma     10/17/2016
Ocular Therapeutix (OCUL) Begins Enrollment In First Phase 3 Clinical Trial With OTX-TP (Sustained Release Travoprost) For The Treatment Of Glaucoma And Ocular Hypertension     10/5/2016
Glaukos Release: New Study Underscores Ability Of Istent Trabecular Micro-Bypass Stent To Achieve Sustained Reductions In IOP And Medication Use In Glaucoma Patients Undergoing Cataract Surgery     9/27/2016
International Study Shows Favorable 3-Year Results Of 2 Glaukos Istent Trabecular Micro-Bypass Stents As Initial Treatment For Naïve Glaucoma     9/23/2016
Heidelberg Engineering Receives FDA Clearance To Market SPECTRALIS OCT Glaucoma Module Premium Edition     9/21/2016
Sight Sciences Announces CE Mark Approval For And Successful Commercial Experiences With The VISCO360 Viscosurgical System For The Surgical Treatment Of Glaucoma     9/9/2016
IRIDEX (IRIX) Announces Long-Term Glaucoma Efficacy Data For Patients Treated With MicroPulse P3 Probe Technology     9/7/2016
Inotek (ITEK) Announces The Completion Of The Recruitment Phase Of MATrX-1, The First Phase 3 Clinical Trial Of Trabodenoson For Glaucoma     8/24/2016
Sight Sciences Receives Full Investigational Device Exemption (IDE) Approval From The US FDA To Initiate The VISCO360 Versus SLT Glaucoma Trial     7/27/2016
OphthaliX Inc. Announces Phase II Glaucoma Data     7/5/2016
Allergan (AGN) Announces FDA Acceptance Of The 510(K) Premarket Notification Filing For The XEN Glaucoma Treatment System     6/15/2016
Ocular Therapeutix (OCUL) Reports First Quarter 2016 Financial Results And Provides Corporate Update     5/10/2016
Isarna Therapeutics Presents First Interim Phase I Data For ISTH0036 In Advanced Glaucoma At Association for Research in Vision & Ophthalmology 2016 Annual Conference     5/4/2016

//-->